Advanced search

116 Results

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Novartis Eyes Sale of Listed Unit in India	22/03	CI
AI buzzes Davos, but CEOs wrestle with how to make it pay	17/01	RE
Novartis drops pursuit of Cytokinetics - source	12/01	RE
Novartis : Financial Results – Q3 2023	24/23/24	PU
Novartis AG : Sandoz takes its first steps on the stock exchange	04/23/04
What happens when a $2 million gene therapy is not enough	12/23/12	RE
Novartis Seeks M&A	25/23/25	CI
Novartis Seeks M&A	09/23/09	CI
Novartis : Financial Results – Q3 2022	25/22/25	PU
Novartis to Seek Acquisitions	22/22/22	CI
Novartis : Amendment to Annual Report by Foreign Issuer (Form 20-F/A)	27/22/27	PU
Novartis Seeks Bolt-On Acquisitions	02/22/02	CI
Transcript : Novartis AG Presents at Co-Creating Impact Summit, Dec-02-2021	02/21/02
NBC Universal : CNBC to Host First Ever “Evolve Global Summit” on June 16	03/21/03	PU
Novartis : Annual Review 2020	26/21/26	PU
Transcript : Novartis AG, Q4 2019 Earnings Call, Jan 29, 2020	29/20/29
Cboe Global Markets : Progenics To Sends Letter To Shareholders, Urges Vote For WHITE Proxy Card	14/19/14	PU
Progenics to Mail Letter to Shareholders	14/19/14	GL
Transcript : Novartis AG, Q4 2018 Earnings Call, Jan 30, 2019	30/19/30
Novartis : rises to second place in 2018 Access to Medicine Index	20/18/20	GL
Transcript : Genmab A/S Presents at Goldman Sachs 39th Annual Global Healthcare Conference, Jun-12-2018 04:00 PM	13/18/13
Novartis : readies to auction U.S. generic pills business - sources	16/18/16	RE
Novartis : appoints Elizabeth Barrett as Oncology Head	11/18/11	GL
Transcript : Novartis AG - Special Call	13/17/13
Moncef Slaoui Joins Medicxi	19/17/19	BU
Fiat Chrysler Automobiles : European shares slip on worries over North Korea nuclear test	04/17/04	RE
Novartis AG Announces Executive Changes	04/17/04	CI
Novartis : announces CEO Joseph Jimenez to retire from in 2018. Vasant Narasimhan appointed CEO, effective February 1, 2018.	04/17/04	GL
Novartis : NEJM publishes full analysis of Rydapt® (midostaurin) Phase III RATIFY trial in newly diagnosed FLT3-mutated acute myeloid leukemia (AML)	23/17/23	GL
Novartis : presents data demonstrating efficacy of AMG 334 (erenumab) in migraine prevention at the American Headache Society Annual Meeting	09/17/09	GL
Novartis : ' new analyses reinforce the potential of Ultibro® Breezhaler® for COPD patients historically treated with steroids	23/17/23	GL
Novartis : NIH study in NEJM shows Novartis drug eltrombopag as first-line therapy with standard treatment improves responses in severe aplastic anemia	20/17/20	GL
Novartis : to strengthen R&D pipeline by in-licensing ECF843 for ophthalmic indications	06/17/06	GL
Novartis : New analysis shows Novartis Entresto improves glycemic control in reduced ejection fraction heart failure patients with diabetes	20/17/20	PU
Novartis : New analysis shows Novartis Entresto improves glycemic control in reduced ejection fraction heart failure patients with diabetes	18/17/18	GL
Novartis : invests in next generation therapies to reduce cardiovascular risk in patients with underlying lipid disorders	16/17/16	PU
Novartis : invests in next generation therapies to reduce cardiovascular risk in patients with underlying lipid disorders	06/17/06	GL
Novartis reaches agreement to buy Texas-based Encore Vision	20/16/20	RE
Novartis : bolsters ophthalmology pipeline through acquisition of Encore Vision, Inc.	20/16/20	GL
Novartis : announces exclusive option, collaboration and license agreement with Conatus to develop new oral treatments for chronic liver diseases	20/16/20	GL
Novartis : says buys Ziarco Group to expand skin care portfolio	16/16/16	RE
Novartis : bolsters innovative dermatology portfolio through acquisition of Ziarco Group Limited	16/16/16	GL
Novartis : provides update on pegpleranib Phase III clinical trial program in patients with neovascular age-related macular degeneration (nAMD or wet AMD)	12/16/12	GL
Novartis : ' Ultibro® Breezhaler® improved lung function and COPD symptoms after direct switch from previous treatment	08/16/08	GL
Novartis : commends publication of major report which recommends broad use of dual bronchodilators to treat COPD	21/16/21	GL
Novartis : announces AMG 334 significantly reduces monthly migraine days in second pivotal Phase III episodic migraine study	17/16/17	GL
Novartis : presents new Cosentyx data showing long-lasting efficacy in psoriatic arthritis over 3 years including patient-reported pain	14/16/14	GL
Novartis : reports over half of psoriasis patients do not reach the achievable treatment goal of clear skin in largest global survey	03/16/03	GL
Novartis : late-breaking data show Cosentyx delivers high and long-lasting skin clearance over 4 years for psoriasis patients	01/16/01	GL
Novartis : announces Phase III study shows AMG 334 significantly reduces monthly migraine days in people with episodic migraine	29/16/29	GL

No results for this search

+201.5% on SUPER MICRO COMPUTER since our purchase on February 17, 2023

Replicate our performance

fermer